GI & Hepatology News Home / Upadacitinib ranked first for UC induction in network metaanalysis

Upadacitinib ranked first for UC induction in network meta-analysis

Interleukin-23 p19 inhibitors ranked most favorably for serious adverse events and discontinuations across 33 trials, though the authors rated confidence in the safety estimates as lower.

Share

stub items
2 Topic Commentaries

Topic Name

  • Scientist LastName, Ph.D.

    Internal Medicine

    •

    Institution Name

    Multiple stab wounds have been linked to negative health outcomes

    Source
  • Scientist LastName, Ph.D.

    Internal Medicine

    •

    Institution Name

    Multiple stab wounds have been linked to negative health outcomes

    Source